Genomic instability in 1p and human malignancies

Genes Chromosomes and Cancer

Volumn 16, Issue 4, 1996, Pages 211-229

  Schwab, Manfred ^a   Praml, Christian ^a   Amler, Lukas C ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGENESIS; CHROMOSOME 1P; CHROMOSOME ABERRATION; CHROMOSOME MAP; GENETIC STABILITY; GENOME; HUMAN; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 1; HUMANS; MUTATION; NEOPLASMS;

EID: 0029774136     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199608)16:4<211::AID-GCC1>3.0.CO;2-0     Document Type: Review

References (232)

1. Amler LC, Corvi R, Praml C, Savelyeva L, Le Paslier D, Schwab M (1995a) A reciprocal translocation (1;15)(36.2;q24) in a neuroblastoma cell line is accompanied by DNA duplication and may signal the site of a putative tumor suppressor gene. Oncogene 10:1095-1101.
2. Amler LC, Corvi R, Praml C, Savelyeva L, Le Paslier D, Schwab M (1995b) Reciprocal translocation at 1p36.2/D1S160 in a neuroblastoma cell line: Isolation of a YAC clone at the break. Europ J Cancer 31A:527-530.
3. Aplan PD, Lombardi DP, Ginsberg AM, Cossman J, Bertness VL, Kirsch IR (1990) Disruption of the human SCL locus by "illegitimate" V-(D)-J recombinase activity. Science 250:1426-1429.
4. Aplan PD, Raimondi SC, Kirsch IR (1992) Disruption of the SCL gene by a t(1;3) translocation in a patient with T-cell acute lymphoblastic leukemia. J Exp Med 176:1301-1310.
5. Aplan PD, Johnson BE, Russel E, Chervinsky DS, Kirsch IR (1995) Cancer Res 55:1917-1921.
6. Ariyama T, Inazawa J, Ezaki T, Nakamura Y, Horii A, Abe T (1995) High-resolution cytogenetic mapping of the short arm of chromosome 1 with newly isolated 411 cosmid markers by fluorescence in situ hybridization: The precise order of 18 markers on 1p36.1 on prophase chromosomes and "stretched" DNAs. Genomics 25: 114-123.
7. Atkin NB (1986) Chromosome 1 aberrations in cancer. Cancer Genet Cytogenet 21:279-285.
8. Atkin NB, Baker MC (1979) Chromosome 1 in 26 carcinomas of the cervix uteri: Structural and numerical changes. Cancer 44:604-613.
9. Atkin NB, Baker MC (1985) Cytogenetic study of ten carcinomas of the bladder: Involvement of chromosomes 1 and 11. Cancer Genet Cytogenet 15:253-268.
10. Bader SA, Fasching C, Brodeur GM, Stanbridge EJ (1991) Dissociation of suppression of tumorigenicity and differentiation in vitro effected by transfer of single human chromosomes into human neuroblastoma cells. Cell Growth & Differentiation 2:245-255.
11. Bajalica S, Brøndum-Nielsen K, Sørensen A-G, Tinggaard Pedersen N, Kristoffersson U, Åkerman M, Anderson M, Pisa P, Nordenskjöld M (1995) Characterization of add(I)(p36) in non-Hodgkin lymphomas by fluorescence in situ hybridization. Genes Chromosom Cancer 13:34-39.
12. Balaban GB, Herlyn M, Clark Jr WH, Nowell PC (1986) Karyotypic evolution in human malignant melanoma. Cancer Genet Cytogenet 19:113-122.
13. Bale SJ, Chakravarti A, Greene MH (1986) Cutaneous malignant melanoma and familial dysplastic nevi: Evidence for autosomal dominance and pleiotropy. Am J Hum Genet 38:188-196.
14. Bale SJ, Dracopoli NC, Greene MH, Gerhard DS, Housman DE (1987) Linkage analysis of melanoma and dysplastic nevus syndrome with polymorphic loci on human chromosome 1p. Cytogenet Cell Genet 46:575.
15. Bale SJ, Dracopoli NC, Tucker MA, Clark Jr WH, Fraser M, Stanger BZ, Green P, Donis-Keller H, Housman DE, Greene MH (1989) Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p. New Engl J Med 320:1367-1372.
16. Bardi G, Johansson B, Pandis N, Heim S, Mandahl N, Andrén-Sandberg Å, Hägerstrand I, Mitelman F (1992) Cytogenetic findings in three primary hepatocellular carcinomas. Cancer Genet Cytogenet 58:191-195.
17. Bardi G, Johansson B, Pandis N, Bak-Jensen E, Orndal C, Heim S, Mandahl N, Andrén-Sandberg Å, Mitelman F (1993a) Cytogenetic aberrations in colorectal adenocarcinomas and their correlation with clinicopathologic features. Cancer 71:306-314.
18. Bardi G, Johansson B, Pandis N, Mandahl N, Bak-Jensen E, Lindstrom C, Tornqvist A, Frederiksen H, Andren-Sandberg A, Mitelman F, Heim S (1993b) Cytogenetic analysis of 52 colorectal carcinomas: Non-random aberration pattern and correlation with pathologic parameters. Int J Cancer 55:422-428.
19. Bardi G, Pandis N, Fenger C, Kronborg O, Bomme L, Heim S (1993c) Deletion of 1p36 as a primary chromosomal aberration in intestinal tumorigenesis. Cancer Res 53:1895-1898.
20. Bardi G, Johansson B, Pandis N, Mandahl N, Bak-Jensen E, Andrén-Sandberg Å, Mitelman F, Heim S (1993d) Karyotypic abnormalities in tumours of the pancreas. Br J Cancer 67:1106-1112.
21. Bardi G, Sukhikh T, Pandis N, Fenger C, Kronborg O, Heim S (1995) Karyotypic characterization of colorectal adenocarcinomas. Genes Chromosom Cancer 12:97-109.
22. Barker PE, Savelyeva L, Schwab M (1993) Translocation junctions cluster at the distal short arm of chromosome 1 (1p36.1-2) in human neuroblastoma cells. Oncogene 8:3353-3358.
23. Barnas CM, Onyango P, Ellmeier W, Lengauer C, Kleiner E, Henn T, Brunner C, Stapleton P, Weith A (1995) Determination and regional assignement of grouped sets of microclones in chromosome 1pter-p35. Genomics 29:607-615.
24. Benedict WF, Weissman BE, Mark C, Stanbridge EJ (1984) Tumorigenicity of human HT1080 fibrosarcoma x normal fibroblast hybrids: Chromosome dosage dependency. Cancer Res 44:3471-3479.
25. Bergman W, Gruis NA, Sandkuijl LA, Frants RR (1994) Genetics of seven Dutch familial atypical multiple Mole-melanoma syndrome families: A review of linkage results including chromosomes 1 and 9. J Invest Dermatol 5:122S-125S.
26. Bernard O, Lecointe N, Jonveaux P, Souyri M, Mauchauffé M, Berger R, Larsen CJ, Mathieu-Mahul D (1991) Two site-specific deletions and t(1;14) translocation restricted to human T-cell acute leukemias disrupt the 5′ part of the tal-1 gene. Oncogene 6:1477-1488.
27. Bernard O, Berger R (1995) Molecular basis of 11q23 rearrangements in hematopoietic malignant proliferations. Genes Chromosom Cancer 13:75-85.
28. Bernard O, Mauchauffe M, Mecucci C, van den Berghe H, Berger R (1994) A novel gene, AF-1p, fused to HRX in t(1;11)(q23), is not related to AF-4, AF-9 nor ENL. Oncogene 9:1039-1045.
29. Berthold F (1990) Overview: Biology of neuroblastoma. In Pochedly C (ed): Neuroblastoma: Tumor biology and therapy. pp. 1-27. Boca Raton, CRC Press.
30. Bièche I, Champème M-H, Merlo G, Larsen C-J, Callahan R, Lidereau R (1990) Loss of heterozygosity of the L-myc oncogene in human breast tumors. Hum Genet 85:101-105.
31. Bièche I, Champème M-H, Matifas F, Crop CS, Callahan R, Lidereau R (1993) Two distinct regions involved in 1p deletion in human primary breast cancer. Cancer Res 53:1900-1994.
32. Bièche I, Champème M-H, Matifas F, Callahan R, Lidereau R (1994) Mise en évidence de deux régions délétées sur le bras court du chromosome 1 dans les tumeurs du sein. Bull Cancer 81:108-113.
33. Biegel JA, Meek RS, Parmiter AH, Conard K, Emanuel BS (1991) Chromosomal translocation t(1;13)(p36;q14) in a case of rhabdomyosarcoma. Genes Chromosom Cancer 3:483-484.
34. Biegel JA, White PS, Marshall HN, Fujimori M, Zackai EH, Scher CD, Brodeur GM, Emanuel BS (1993) Constitutional 1p36 deletion in a child with neuroblastoma. Am J Hum Genet 52:176-182.
35. Blackwell TK, Alt FW (1989) Molecular characterization of the lymphoid V(D)J recombination activity. J Biol Chem 264:10327-10330.
36. Bloomfield CD, Garson M, Volin L, Knuutila S, de la Chapelle A (1985) t(1;3)(p36;q21) in acute nonlymphocytic leukemia: a new cytogenetic-clinopathologic association. Blood 66:1409-1413.
37. Borg Å, Zhang Q-X, Olsson H, Wenngren E (1992) Chromosome 1 alterations in breast cancer: Allelic loss on 1p and 1q is related to lymphogenic metastases and poor prognosis. Genes Chromosom Cancer 5:311-320.
38. Brito-Babapulle V, Atkin NB (1981) Break points in chromosome #1 abnormalities of 218 human neoplasms. Cancer Genet Cytogenet 4:215-225.
39. Brodeur GM, Green AA, Hayes FA, Williams KJ, Williams DL, Tsiatis AA (1981) Cytogenetic features of human neuroblastomas and cell lines. Cancer Res 41:4678-4686.
40. Brown L, Cheng J-T, Chen Q, Siciliano MJ, Crist W, Buchanan G, Baer R (1990) Site-specific recombination of the tal-1 gene is a common occurrence in human T cell leukemia. EMBO J 9:3343-3351.
41. Buetow KH, Murray JC, Israel JL, London WT, Smith M, Kew M, Blanquet V, Brechot C, Redeker A, Govindarajh S (1989) Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma. Proc Natl Acad Sci USA 86: 8852-8856.
42. Burnett RC, Thirman MJ, Rowley JD, Diaz MO (1994) Molecular analysis of the T-cell acute lymphoblastic leukemia-associated t(1;7)(p34;q34) that fuses LCK and TCRB. Blood 84:1232-1236.
43. Cannon-Albright LA, Goldgar DE, Wright EC, Turco A, Jost M, Meyer LJ, Piepkorn M, Zone JJ, Skolnick MH (1990) Evidence against the reported linkage of the cutaneous melanoma-dysplastic nevus syndrome locus to chromosome 1p36. Am J Hum Genet 46:912-918.
44. Cannon-Albright LA, Goldgar DE, Meyer LJ, Lewis CM, Anderson DE, Fountain JW, et al. (1992) Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22. Science 258:1148-1152.
45. Caron H, van Sluis P, van Hoeve M, de Kraker J, Bras J, Slater R, Mannens M, Voûte PA, Westerveld A, Versteeg R (1993) Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification. Nature Genet 4:187-190.
46. Caron H, van Sluis P, van Roy N, de Kraker J, Speleman F, Voûte PA, Westerveld A, Slater R, Versteeg R (1994) Recurrent 1;17 translocations in human neuroblastoma reveal nonhomologous mitotic recombination during the S/G2 phase as a novel mechanism for loss of heterozygosity. Am J Hum Genet 55:341-347.
47. Caron H, van Sluis P, de Kraker J, Bökkerink J, Egeler M, Laureys G, Slater R, Westerveld A, Voûte PA, Versteeg R (1995) Allelic loss of chromosome 1p identifies neuroblastoma patients at high risk of an unfavourable outcome. N Engl J Med (in press).
48. Carroll AJ, Crist WM, Link MP, Amylon MD, Pullen DJ, Ragab AH, Buchanan GR, Wimmer RS, Vietti TJ (1990) The t(1;14) (p34;q11) is nonrandom and restricted to T-cell acute lymphoblastic leukemia: A pediatric oncology group study. Blood 76: 1220-1224.
49. Castedo SMMJ, de Jong B, Oosterhuis JW, Seruca R, Idenburg VJS, Dam A, te Meerman G, Koops HS, Sleijfer DT (1989) Chromosomal changes in human primary testicular nonseminomatous germ cell tumors. Cancer Res 49:5696-5701.
50. Chaganti RSK, Rodriguez E, Bosl GJ (1993) Cytogenetics of male germ cell tumors. N Am Clin Urol 20:55-66.
51. Chen Q, Cheng J-T, Tsai L-H, Schneider N, Buchanan G, Carroll A, Crist W, Ozanne B, Siciliano MJ, Baer R (1990) The tal gene undergoes chromosome translocation in T cell leukemia and potentially encodes a helix-loop-helix protein. EMBO J 9:415-424.
52. Cheng JM, Hiemstra JL, Schneider SS, Naumova A, Cheung N-KV, Cohn SL, Diller L, Sapienza C, Brodeur GM (1993) Preferential amplification of the paternal allele of the N-myc gene in human neuroblastomas. Nature Genetics 4:191-194.
53. Cheng NC, Van Roy N, Chan A, Beitsma M, Westerveld A, Speleman F, Versteeg R (1995) Deletion mapping in neuroblastoma cell lines suggests two distinct tumor suppressor genes in the 1p35-36 region, only one of which is associated with N-myc amplification. Oncogene 10:291-297.
54. Cheng NC, Chan AJK, Beitsma MM, Speleman F, Westerveld A, Versteeg R (1996) A human modifier for class I HLA genes (MEMO-1) maps to chromosomal bands 1p35-36.1. Hum Molec Genet 5:309-317.
55. Christiansen H, Lampert F (1988) Tumour karyotype discriminates between good and bad prognostic outcome in neueroblastoma. Br J Cancer 57:121-126.
56. Christiansen H, Sahin K, Berthold F, Hero B, Terpe H-J, Lampert F (1995) Comparison of DNA aneuploidy, chromosome 1 abnormalities, MYCN amplification and CD44 expression as prognostic factors in neuroblastoma. Europ J Cancer 31A, 541-544.
57. Combaret V, Turc-Carel C, Thiesse P, Rebillard A-C, Frappaz D, Haus O, Philip T, Favrot MC (1995) Sensitive detection of numerical and structural aberrations of chromosome 1 in neuroblastoma by interphase fluorescence in situ hybridization. Comparison with restriction fragment length polymorphism and conventional cytogenetic analyses. Int J Cancer 61:185-191.
58. Couturier-Turpin M-H, Esnous C, Louvel A, Poirier Y, Couturier D (1992) Chromosome 1 in human colorectal tumors. Hum Genet 88:431-438.
59. Cryns VL, Yi SM, Tahara H, Gaz RD, Arnold A (1995) Frequent loss of chromosome arm 1p DNA in parathyroid adenomas. Genes Chromosom Cancer 13:9-17.
60. Davis RJ, D'Cruz CM, Lovell MA, Biegel JA, Barr FG (1994) Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma. Cancer Res 54:2869-2872.
61. Devilee P, van Vliet M, Bardoel A, Kievits T, Kuipers-Dijkshoorn N, Pearson PL, Cornelisse CJ (1991) Frequent somatic imbalance of marker alleles for chromosome 1 in human primary breast carcinoma. Cancer Res 51:1020-1025.
62. Dietrich WF, Lander ES, Smith JS, Moser AR, Gould KA, Luongo C, Borenstein N, Dove W (1993) Genetic identification of Mom1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 75:631-639.
63. Douglass EC, Rowe ST, Valentine M, Parham DM, Berkow R, Bowman WP, Maurer HM (1991) Variant translocations of chromosome 13 in alveolar rhabdomyosarcoma. Genes Chromosom Cancer 3:480-482.
64. Dracopoli NC, Harnett P, Bale SJ, Stanger BZ, Tucker MA, Housman DE, Kefford RF (1989) Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression. Proc Natl Acad Sci USA 86:4614-4618.
65. Dracopoli NC, O'Connell P, Elsner TI, Lalouel J-M, White RL, Buetow KH, Nishimura DY, Murray JC, Helms C, Mishra SK, Donis-Keller H, Hall JM, Lee MK, King M-C, Attwood J, Morton NE, Robson EB, Mahtani M, Willard HF, Royle NJ, Patel I, Jeffreys AJ, Verga V, Jenkins T, Weber JL, Mitchell AL, Bale AE (1991) The CEPH consortium linkage map of human chromosome 1. Genomics 9:686-700.
66. Dracopoli NC, Bruns GAP, Brodeur GM, Landes GM, Matise TC, Seldin MF, Vance JM, Weith A (1994) Report of the first international workshop on human chromosome 1 mapping 1994. Cytogenetic Cell Genet 67:144-165.
67. Dutrillaux B, Gerbault-Seureau M, Zafrani B (1990) Characterization of chromosomal anomalies in human breast cancer. Cancer Genet Cytogenet 49:203-217.
68. Ellmeier W, Aguzzi A, Kleiner E, Kurzbauer R, Weith A (1992) Mutually exclusive expression of a helix-loop-helix gene and N-myc in human neuroblastomas and in normal development. EMBO J 11:2563-2571.
69. Enomoto H, Ozaki T, Takahashi E-I, Nomura N, Tabata S, Takahashi H, Ohnuma N, Tanabe M, Iwai J, Yoshido H, Matsunaga T, Sakiyama S (1994) Identification of human DAN gene, mapping to the putative neuroblastoma tumor suppressor locus. Oncogene 9:2785-2791.
70. Fan Y-S, Li P (1987) Cytogenetic studies of four human lung adenocarcinoma cell lines. Cancer Genet Cytogenet 26:317-325.
71. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61:759-767.
72. Fijneman RJA, Demant P (1995) A gene for susceptibility to small intestinal cancer, ssic1, maps to the distal part of mouse chromosome 4. Cancer Res 55:3179-3182.
73. Finger LR, Kagan J, Christopher G, Kurtzberg J, Hershfield MS, Nowell PC, Croce CM (1989) Involvement of the TCL5 gene on human chromosome 1 in T-cell leukemia and melanoma. Proc Natl Acad Sci USA 86:5039-5043.
74. Fitzgerald TJ, Neale GAM, Raimondi S, Goorha RM (1991) c-tal, a helix-loop-helix protein, is juxtaposed to the T-cell receptor -B chain gene by a reciprocal chromosomal translocation: t(1;7) (p32;q35). Blood 78:2686-3695.
75. Fong C-T, Dracopoli NC, White PS, Merrill PT, Griffith RC, Housman DE, Brodeur GM (1989) Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: Correlation with N-mycamplification. Proc Natl Acad Sci USA 86:3753-3757.
76. Fong C-T, White PS, Peterson K, Sapienza C, Cavenee WK, Kern SE, Vogelstein B, Cantor AB, Look AT, Brodeur GM (1992) Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas. Cancer Res 52:1780-1785.
77. Fountain JW, Bale SJ, Housman DE, Dracopoli NC (1990) Genetics of melanoma. Cancer Surveys 9:645-671.
78. Fujiimori M, Tokino T, Hino O, Kitagawa T, Imamura T, Okamoto E, Mitsunobu M, Ishikawa T, Nakagama H, Harada H, Yagura M, Matsubara K, Nakamura Y (1991) Allelotype study of primary hepatocellular carcinoma. Cancer Res 51:89-93.
79. Gehring M, Berthold F, Edler L, Schwab M, Amler LC (1995) The 1p deletion is not a reliable marker for the prognosis of patients with neuroblastoma. Cancer Res 55:5366-5369.
80. Genuardi M, Tsihira H, Anderson DE, Saunders GF (1989) Distal deletion of chromosome 1p in ductal carcinoma of the breast. Am J Hum Genet 45:73-82.
81. Gerdes H, Chen Q, Elahi AH, Sircar A, Goldberg E, Winawer D, Urmacher C, Winawer SJ, Jhanwar SC (1995) Recurrent deletions involving chromosome 1, 5, 17, and 18 in colorectal carcinoma: possible role in biological and clinical behavior of tumors. Anticancer Res 15:13-24.
82. Gilbert F, Balaban G, Moorhead P, Bianchi D, Schlesinger H (1982) Abnormalities of chromosome 1p in human neuroblastoma tumors and cell lines. Cancer Genet Cytogenet 7:33-42.
83. Gilbert F, Feder M, Balaban G, Brangman D, Lurie DK, Podolsky R, Rinaldt V, Vinikoor N, Weisband J (1984) Human neuroblastomas and abnormalities of chromosomes 1 and 17. Cancer Res 44:5444-5449.
84. Goldstein AM, Dracopoli NC, Ho EC, Fraser MC, Kearns KS, Bale SJ, McBride OW, Clark Jr WJ, Tucker MA (1993) Further evidence for a locus for cutaneous malignant melanoma-dysplastic nevus (CMM/DN) on chromosome 1p, and evidence for genetic heterogeneity. Am J Hum Genet 52:537-550.
85. Goldstein AM, Dracopoli NC, Engelstein M, Fraser MC, Clark WH Jr, Tucker MA (1994) Linkage of cutaneous malignant melanoma/dysplastic nevi to chromosome 9p, and evidence for genetic heterogeneity. Am J Hum Genet 54:489-496.
86. Greene MH, Fraumeni JF Jr (1979) The herditary variant of malignant melanoma. In: Clark WH Jr, Goldman LI, Mastrangelo MJ (eds): Human Malignant Melanoma, pp. 139-166. New York, Grune & Stratton.
87. Greene MH, Goldin LR, Clark Jr WH et al. (1983) Familial cutaneous malignant melanoma: autosomal dominant trait possibly linked to the Rh locus. Proc Natl Acad Sci USA 80:6071-6075.
88. Griffin CA, Hruban RH, Long PP, et al. (1994) Chromosome abnormalities in pancreatic adenocarcinoma. Genes Chromosom Cancer 9:93-100.
89. Gruis NA, Bergman W, Frants RR (1990) Locus for susceptibility to melanoma on chromosome 1p. N Engl J Med 322:853-854.
90. Guyer M, Cann H (1992) A comprehensive genetic linkage map of the human genome. Science 258:67-86.
91. Gyapay G, Morissette J, Vignal A, Dib C, Fizames C, Millasseau P, Marc S, Bernardi G, Lathrop M, Weissenbach J (1994) The 1993-94 Généthon human genetic linkage map. Nature Genetics 7:246-249.
92. Hahn S, Seymour AB, Hoque ATMS, Schutte M, da Costa LT, Redston M, Caldas C, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE (1995) Allelotype of pancreatic adenocarcinoma using xenograft enrichment. Cancer Res 55:4670-4675.
93. Hainsworth PJ, Raphael KL, Stillwell RG, Bennett RC, Garson OM (1992) Rearrangements of chromosome 1p in breast cancer correlates with poor prognostic features. Br J Cancer 66:131-135.
94. Haluska FG, Huebner K, Isobe M, Nishimura T, Croce CM, Vogt PK (1988) Localization of the human JUN protooncogene to chromosome region 1p31-32. Proc Natl Acad Sci USA 85:2215-2218
95. Harnett PR, Kearsley JH, Hayward NK, Dracopoli NC, Kefford RF (1991) Loss of allelic heterozygosity on distal chromosome 1p in Merkel cell carcinoma. A marker of neural crest origins? Cancer Genet Cytogenet 54:109-113.
96. Hashimoto N, Ichikawa D, Arakawa Y, Date K, Ueda S, Nakagawa Y, Horii A, Nakamura Y, Abe T, Inazawa J (1995) Frequent deletions of chromosome 1p in oligodendroglial tumors revealed by double-target fluorescence in situ hybridization and microsatellite analysis (in press).
97. Hayashi Y, Kanda N, Inaba T, Hanada R, Nagahara N, Muchi H, Yamamoto K (1989) Cytogenetic findings and prognosis in neuroblastoma with emphasis on marker chromosome 1. Cancer 63: 126-132.
98. Heim S, Mitelman F (1987) Cancer Cytogenetics. New York, Alan R Liss Inc.
99. Heim S, Mitelman F (1995) Cancer Cytogenetics, 2nd Ed. New York, Wiley-Liss.
100. Hershfield MS, Kurtzberg J, Harden E, Moore JO, Whang-Peng J, Haynes BF (1984) Conversion of a stem cell leukemia from a T-lymphoid to a myeloid phenotype induced by the adenosine deaminase inhibitor 2́-deoxycoformycin. Proc Natl Acad Sci USA 81:253-257.
101. Herzog CR, Wang Y, You M (1995) Allelic loss of distal chromosome 4 in mouse lung tumors localizes a putative tumor suppressor gene to a region homologous with human chromosome 1p36. Oncogene 11:1811-1815.
102. Hoggard N, Brintnell B, Howell A, Weissenbach J, Varley J (1995a) Allelic imbalance on chromosome 1 in human breast cancer. II. microsatellite repeat analysis. Genes Chromosom Cancer 12:24-31.
103. Hoggard N, Hey Y, Brintnell B, James L, Jones D, Mitchell E, Weissenbach J, Varley J (1995b) Identification and cloning of yeast artificial chromosomes of a region of elevated loss of heterozygosity on chromosome 1p31.1 in human breast cancer. Genomics 30:233-243.
104. Hunt JD, Tereba A (1990) Molecular evaluation of abnormalities of the short arm of chromosome 1 in neuroblastoma. Genes Chromosom Cancer 2:137-146.
105. Hussussian CT, Struewing JP, Goldstein A, Higgins PAT, Ally DS, Sheahan MD, Clark WH, Tucker MA, Dracopoli NC (1994) Germline p16 mutations in familial melanoma. Nature Genet 18: 15-21.
106. Huynh HT, Larsson C, Narod S, Pollak M (1995) Tumor suppressor activity of the gene encoding mammary-derived growth inhibitor. Cancer Res 55:2225-2231.
107. Islam MQ, Szpirer J, Szpirer C, Islam K, Dasnoy J-F, Levan G (1989) A gene for the suppression of anchorage independence is located in rat chromosome 5 bands q22-23, and the rat alpha-interferon locus maps at the same region. J Cell Sciences 92:147-162.
108. Janssen JWG, Ludwig W-D, Sterry W, Bartram CR (1993) SILTAL1 deletion in T-cell acute lymphoblastic leukemia. Leukemia 7:1204-1210.
109. Järvelä I, Schleutker J, Haataja L, Santavuori P, Puhakka L, Manninen T, Palotie A, Sandkuijl LA, Renlund M, White R, Aula P, Peltonen L (1991) Infantile form of neuronal ceroid lipofuscinosis (CLN1) maps to the short arm of chromosome 1. Genomics 9:170-173.
110. Jin Y-S, Mandahl N, Heim S, Schuller H, Mitelman F (1988) Isochromosome i(8q) or i(9q) in three adenocarcinomas of the lung. Cancer Genet Cytogenet 33:11-17.
111. Johansson B, Waldenström J, Hasselblom S, Mitelman F (1995) Waldenström's macroglobulinemia with the AML/MDS-associated t(1;3)(p36;q21). Leukemia 9, 1136-1138.
112. Johnson BE, Makuch RW, Simmons AD, Gazdar AF, Burch D, Cashell AW (1988) Myc family DNA amplification in small cell lung cancer patients' tumors and corresponding cell lines. Cancer Res 48:5163-5166.
113. Jonsson OF, Kitchens RL, Baer RJ, Buchanan GR, Smith RG (1991) Rearrangements of the tal-1 locus as clonal markers for T cell acute lymphoblastic leukemia. J Clin Invest 87:2029-2035.
114. Jonasson J, Povey S, Harris H (1977) The analysis of malignancy by cell fusion. VII. Cytogenetic analysis of hybrids between malignant and diploid cells and of tumours derived from them. J Cell Sci 24:217-254.
115. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day III RS, Johnson BE, Skolnick MH (1994a) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436-440.
116. Kamb A, Shattuck-Eidens D, Eeles R, Liu Q, Gruis NA, Ding W, Hussey C, Tran T, Miki Y, et al. (1994b) Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nature Genet 8:22-26.
117. Kefford RF, Salmon J, Shaw HM, Donald JA, McCarthy WH (1991) Hereditary melanoma in Australia: variable association with dysplastic nevi and absence of genetic linkage to chromosome 1p. Cancer Genet Cytogenet 51:45-55.
118. Keppler-Noreuil KM, Carroll AJ, Finley WH, Rutledge SL (1995) Chromosome 1p terminal deletion: report of new findings and confirmation of two characteristic phenotypes. J Med Genet 32: 619-622.
119. Khosla S, Patel VM, Hay ID, Schaid DJ, Grant CS, van Heerden JA, Thibodeau SN (1991) Loss of heterozygosity suggests multiple genetic alterations in pheochromocytomas and medullary thyroid carcinomas. J Clin Invest 87:1691-1699.
120. Konstantinova LN, Fleischman EV, Knisch VI, Perevozchikov AG, Kopnin BP (1991) Karyotype pecularities of human colorectal adenocarcinomas. Hum Genet 86:491-496.
121. Kraus JA, Koopmann J, Kaskel P, Maintz D, Brandner S, Schramm J, Louis DN, Wiestler OD, von Deimling A (1995) Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma. J Neuropath Exp Neurol 54:91-95.
122. Kugoh H, Nakagawa Y, Mitsuya K, Mita T, Suzuki M, Suzuki N, Uejima H, Yuasa Y, Oshimura M (1995) Isolation and mapping of 186 new DNA markers on human chromosome 1. Genomics 27: 207-210.
123. Kuroki T, Fujiwara Y, Tsuchiya E, Nakamori S, Imaoka S, Kanematsu T, Nakamura Y (1995) Accumulation of genetic changes during development and progression of hepatocellular carcinoma: Loss of heterozygosity on chromosome arm 1 occurs at an early stage of hepatocarcinogenesis. Genes Chromosom Cancer 13: 163-167.
124. Kushner BH, Gilbert F, Helson L (1986) Familial neuroblastoma: case reports, literature review, and etiologie considerations. Cancer 57:1887-1893.
125. Kusyk CJ, Romsdahl MM (1986) Cytogenetic study of a Merkel Cell Carcinoma. Cancer Genet Cytogenet 20:311-316.
126. Lahti JM, Valentine M, Xiang J, Jones B, Amann J, Grenet J, Richmond G, Look AT, Kidd VJ (1994) Alterations in the PITSLRE protein kinase gene complex on chromosome 1p36 in childhood neuroblastoma. Nature Genetics 7:370-375.
127. Laureys G, Speleman F, Opdenakker G, Benoit Y, Leroy J (1990) Constitutional translocation t(1;17)(p36;q12-21) in a patient with neuroblastoma. Genes Chromosom Cancer 2:252-254.
128. Laureys G, Speleman F, Versteeg R, van der Drift P, Chan A, Leroy J, Francke U, Opdenakker G, Van Roy N (1995) Constitutional translocation t(1;17)(p36.31-p36.13;q11.2-q12.1) in a neuroblastoma patient. Establishment of somatic cell hybrids and identification of PND/A12M2 on chromosome 1 and NF1/SCYA7 on chromosome 17 as breakpoint flanking single copy markers. Oncogene 10:1087-1093.
129. Legha SS (1989) Current therapy for malignant melanoma. Seminars in Oncology 16:34-44.
130. Leister I, Weith A, Brüderlein S, Cziepluch C, Kangwanpong D, Schlag P, Schwab M (1990) Human colorectal cancer: High frequency of deletions at chromosome 1p35. Cancer Res 50:7232-7235.
131. Levanon D, Negreanu V, Bernstein Y, Bar-Am I, Avivi L, Groner Y (1994) AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization. Genomics 23:425-432.
132. Limon J, Cin PD, Sait SNJ, Karakousis C, Sandberg AA (1988) Chromosome changes in metastatic human melanoma. Cancer Genet Cytogenet 30:201-211.
133. Lothe RA, Norheim Andersen S, Hofstad B, Meling GI, Peltomäki P, Heim S, Brøgger A, Vatn M, Rognum TO, Børresen A-L (1995) Deletion of 1p loci and microsatellite instability in colorectal polyps. Genes Chromosom Cancer 14:182-188.
134. Lukeis R, Irving L, Garson M, Hasthorpe S (1990) Cytogenetics of non-small cell lung cancer: Analysis of consistent non-random abnormalities. Genes Chromosom Cancer 2:116-124.
135. Lukeis R, Ball D, Irving L, Garson OM, Hasthorpe S (1993) Chromosome abnormalities in non-small cell lung cancer pleural effusions: Cytogenetic indicators of disease subgroups. Genes Chromosom Cancer 8:262-269.
136. MacLean-Hunter S, Mäkelä TP, Grzeschiczek A, Alitalo K, Möröy T (1994) Expression of a RLF/L-MYC minigene inhibits differentiation of embryonic stem cells and embryoid body formation. Oncogene 9:3509-3517.
137. Min-induced intestinal neoplasia. Cell 81:957-966.
138. Mäkelä TP, Saksela K, Evan G, Alitalo K (1991) A fusion protein formed by L-myc and a novel gene in SCLC. EMBO J 10:1331-1335.
139. Maris JM, White PS, Beltinger CP, Sulman EP, Castleberry RP, Shuster JJ, Look AT, Brodeur GM (1995) Significance of chromosome 1p loss of heterozygosity in neuroblastoma. Cancer Res. 55:4664-4669.
140. Mars WM, Saunders GF (1990) Chromosomal abnormalities in human breast cancer. Cancer Metastasis Rev 9:35-43.
141. Martinsson T, Weith A, Cziepluch C, Schwab M (1989) Chromosome 1 deletions in human neuroblastomas: Generation and fine mapping of microclones from the distal 1p region. Genes Chromosom Cancer 1:67-78.
142. Martinsson T, Sjöberg R-M, Hedborg F, Kogner P (1995) Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms. Cancer Res 55:5681-5686.
143. Mathew CGP, Smith BA, Thorpe K, Wong Z, Royle NJ, Jeffreys AJ, Ponder BAJ (1987) Deletion of genes on chromosome 1 in endocrine neoplasia. Nature 328:524-526.
144. Mathew S, Murty VWS, Bosl GJ, Chaganti RSK (1994) Loss of heterozygosity identifies multiple sites of allelic deletions on chromosome 1 in human male germ cell tumors. Cancer Res 54: 6265-6269.
145. Meyer LJ, Zone JH (1994) Genetics of cutaneous melanoma. J Invest Dermatol 103:112S-116S.
146. Mead RS, Cowell JK (1995) Molecular characterization of a (1;10)(p22;q21) constitutional translocation from a patient with neuroblastoma. Cancer Genet Cytogenet 81:151-157.
147. Mitchell ELD, Santibanez-Koref MF (1990) 1p13 is the most frequent involved band in structural chromosomal rearrangements in human breast cancer. Genes Chromosom Cancer 2:278-289.
148. Mitelman F (1994) Catalog of chromosome aberrations in cancer, 5th ed. Wiley-Liss, New York.
149. Moir DJ, Jones PAE, Pearson J, Duncan JR, Cook P, Buckle VJ (1984) A new translocation, t(1;3)(p36;q21), in myelodysplastic disorders. Blood 64:553-555.
150. Moley JF, Brother MB, Fong C-T, White PS, Baylin SB, Nelkin B, Wells SA, Brodeur GM (1992) Consistent association of 1p loss of heterozygosity with Pheochromocytomas from patients with multiple endocrine neoplasia type 2 syndromes. Cancer Res 52:770-774.
151. Morton NE (1991) Parameters of the human genome. Proc Natl Acad Sci USA 88:7474-7476.
152. Muleris M, Salmon R-J, Dutrillaux B (1990) Cytogenetics of colorectal adenocarcinomas. Cancer Genet Cytogenet 46:143-156.
153. Munn KE, Walker RA, Varley JM (1995) Frequent alterations of chromosome 1 in ductal carcinoma in situ of the breast. Oncogene 10:1653-1657.
154. Murray JC, Buetow KH, Weber JL, Ludwigsen S, Sherpbier-Heddema T, et al. (1994) A comprehensive human linkage map with centimorgan density. Science 265:2049-2054.
155. Nadeau JH, Davisson MT, Doolittle DP, Grant P, Hillyard AL, Kosowsky M, Roderick TH (1991) Comparative map for mice and humans. Mammalian Genome 1:461-515.
156. Nagai H, Negrini M, Carter SL, Gillum DR, Rosenberg AL, Schwartz GF, Croce CM (1995) Detection and cloning of a common region of loss of heterozygosity at chromosome 1p in breast cancer. Cancer Res 55:1752-1757.
157. Nancarrow DJ, Palmer JM, Walters MK, Kerr BM, Hafner GJ, Garske L, McLeod GR, Hayward NK (1992) Exclusion of the familial melanoma locus (MLM) from the PND/D1S47 and MYCL1 regions of chromosome arm 1p in 7 Australian pedigrees. Genomics 12:18-25.
158. Nancarrow DJ, Mann GJ, Holland EA, Walker GJ, Beaton SC, Walters MK, Luxford C, et al. (1993) Confirmation of chromosome 9p linkage in familial melanoma. Am J Hum Genet 53:936-942.
159. Nau MM, Brooks BJ, Battney J, Sausville E, Gazdar AF, Kirsch IR, McBride OW, Bertness V, Hollis GF, Minna JD (1985) L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer. Nature 318:69-73.
160. O'Brien SJ, Womack JE, Lyons LA, Moore KJ, Jenkins NA, Copeland NG (1993) Anchored reference loci for comparative genome mapping in mammals. Nature Genetics 3:103-112.
161. Oláh E, Balogh E, Kovács I, Kiss A (1989) Abnormalities of chromosome 1 in relation to human malignant diseases. Cancer Genet Cytogenet 43:179-194.
162. Othmane KB, Middleton LT, Loprest LJ, Wilkinson KM, Lennon F, Rozear MP, Stajich JM, Gaskell PC, Roses AD, Pericak-Vance MA, Vance JM (1993) Localization of a gene (CMT2A) for autosomal dominant Charcot-Marie-Tooth disease Type 2 to chromosome 1p and evidence of genetic heterogeneity. Genomics 17: 370375.
163. Pal N, Wadey RB, Buckle B, Yeomans E, Pritchard J, Cowell JK (1990) Preferential loss of maternal alleles in sporadic Wilms' tumour. Oncogene 5:1665-1668.
164. Pandis N, Jin Y, Gorunova L, Petersson C, Bardi G, Idvall I, Johansson B, Ingvar C, Mandahl N, Mitelman F, Heim S (1995) Chromosome analysis of 97 primary breast carcinomas: Identification of eight karyotypic subgroups. Genes Chromosom Cancer 12:173-185.
165. Pasquali F, Francesconi D, Casalone R, Ippoliti G (1979) Partial trisomy
166. Peter M, Michon J, Viehl P, Neuenschwander S, Nakamura Y, Sonsino E, Zucker JM, Vergnaud G, Thomas G, Delattre O (1992) PCR assay for chromosome 1p deletion in small neuroblastoma samples. Int J Cancer 52:544-548.
167. Piepkorn MW (1994) Genetic basis of susceptibility to melanoma. J Am Acad Dermatol 31:1022-1039.
168. Praml C, Finke LH, Herfarth C, Schlag P, Schwab M, Amler L (1995a) Deletion mapping defines different regions in 1p34.2-pter that may harbor genetic information related to human colorectal cancer. Oncogene 11:1357-1362.
169. Praml C, Savelyeva L, Le Paslier D, Siracusa LD, Buchberg AM, Schwab M, Amler LC (1995b) The human homolog of a candidate for the Mom1 Locus, the Secretory Type II Phospholipase A2 (PLA2S-II), maps to 1p35-1p36. 1/D1S199. Cancer Res 55:5504-5506.
170. Rabbitts TH (1991) Translocations, master genes, and differences between the origins of acute and chronic leukemias. Cell 67:641-644.
171. Raimondi SC, Privitera E, Williams DL, Look AT, Behm F, Rivera GK, Crist WM, PUI CH (1991) New recurring chromosomal translocations in childhood acute lymphoblastic leukemia. Blood 77:2016-2021.
172. Reifenberger J, Reifenberger G, Liu L, James CD, Wechsler W, Collins VP (1994) Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am J Path 145:1175-1190.
173. Reish O, Berry S, Hirsch B (1995) Partial monosomy of chromosome 1p36.3: Characterization of the critical region and delineation of a syndrome. Am J Med Genet 59:467-475.
174. 2 gene alterations in human colorectal cancer. Cancer Res 55:5184-5186.
175. Ritke MK, Shah R, Valentine M, Douglass EC, Tereba A (1989) Molecular analysis of chromosome 1 abnormalities in neuroblastoma. Cytogenet Cell Genet 50:84-90.
176. Robb L, Rasko JEJ, Bath ML, Strasser A, Begley CG (1995) scl, a gene frequently activated in human T cell leukaemia, does not induce lymphomas in transgenic mice. Oncogene 10:205-209.
177. Rowley JD (1977) Mapping of human chromosomal regions related to neoplasia: Evidence from chromosomes 1 and 17. Proc Natl Acad Sci USA 74:5729-5733.
178. Savelyeva L, Corvi R, Schwab M (1994) Translocation involving 1p and 17q is a recurrent genetic alteration of human neuroblastoma cells. Am J Hum Genet 55:334-340.
179. Scheres JMJC, Hustinx TWJ, Holdrinet RSG, Geraedts JPM, Hagemeijer A, van der Blij-Philipsen M (1984) Translocation 1;7 in dyshematopoiesis: Possibly induced with a non-random geographic distribution. Cancer Genet Cytogenet 12:283-294.
180. Schleiermacher G, Peter M, Michon J, Hugot J-P, Vielh P, Zucker J-M, Magdelénat H, Thomas G, Delattre O (1994) Two distinct deleted regions on the short arm of chromosome 1 in neuroblastoma. Genes Chromosom Cancer 10:275-281.
181. Schleiermacher G, Delattre O, Peter M, Mosseri V, Delonlay P, Thomas G, Zucker J-M, Magdelénat H, Michon J (1995) Clinical relevance of deletion of the short arm of chromosome 1 in neuroblastoma: A single institution study. Int J Oncol (in press).
182. Schroeder WT, Chao L-Y, Dao DD, Strong LC, Pathak S, Riccardi V, Lewis WH, Saunders GF (1987) Nonrandom loss of maternal chromosome 11 alleles in Wilms tumors. Am J Hum Genet 40: 413-420.
183. Schwab M (1991) Is there a neuroblastoma anti-oncogene? Advances in Neuroblastoma Research 3 in Evans AE, D'Angio GJ, Knudson Jr AG, Seeger RC (eds): Progress in clinical and biological research. Volume 366. New York: Wiley-Liss, pp. 1-9.
184. Schwab M, Bishop JM (1988) Sustained expression of the human protooncogene MYCN rescues rat embryo cells from senescence. Proc Natl Acad Sci USA 85:9585-9589.
185. Schwab M, Pearson A (1995) Special Issue: Europ J Cancer 31A: Genetics, cellular biology and clinical management of human neuroblastoma. Oxford: Pergamon.
186. Schwab M, Alitalo K, Klempnauer K-H, Varmus HE, Bishop JM, Gilbert F, Brodeur G, Goldstein M, Trent J (1983) Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature 305:245-248.
187. Schwab M, Ellison JE, Busch M, Rosenau W, Varmus HE, Bishop JM (1984) Enhanced expression of the human N-myc gene consequent co amplification of DNA may contribute to malignant progression of neuroblastoma. Proc Natl Acad Sci USA 81:4940-4944.
188. Schwab M, Varmus HE, Bishop JM (1985) Human N-may gene contributes to neoplastic transformation of mammalian cells in-culture. Nature 316:160-162.
189. Schwab M, Brüderlein S, van der Bosch K, Weith A, Leister I, Cziepluch C, Amler L, Schlag P (1990) Genetic alterations in colorectal cancers in correlation to clinical parameters. In: Utsunomiya J, Lynch HT (eds) Hereditary colorectal cancer. Tokyo, Springer-Verlag, pp 509-516.
190. Schwab M, Corvi R, Amler LC (1995) N-MYC oncogene amplification: A consequence of genomic instability in human neuroblastoma. The Neuroscientist 1:277-285.
191. Shirashi M, Noguchi M, Shimosato Y, Sekiya T (1989) Amplification of protooncogenes in surgical specimens of human lung carcinomas. Cancer Res 49:6474-6479.
192. Simon D, Aden DP, Knowles BB (1982) Chromosomes of human hepatoma cell lines. Int J Cancer 30:27-33.
193. Simon D, Munoz SJ, Maddrey WC, Knowles BB (1990) Chromosomal rearrangements in a primary hepatocellular carcinoma. Cancer Genet Cytogenet 45:255-260.
194. Simon D, Knowles BB, Weith A (1991) Abnormalities of chromosome 1 and loss of heterozygosity on 1p in primary hepatomas. Oncogene 6:765-770.
195. Sozzi G, Bertoglio MG, Pilotti S, Rilke F, Pierotti MA, Della Porta G (1988) Cytogenetic studies in primary and metastatic neuroendocrine Merkel cell carcinoma. Cancer Genet Cytogenet 30:151-158.
196. 2 genes that map to human chromosome 1p35-36 are not mutated in individuals with attenuated adenomatous polyposis coli. Cancer Res 56:955-958.
197. Sreekantaiah C, Bhargava MK, Shetty NJ (1988) Chromosome 1 abnormalities in cervical carcinoma. Cancer 62:1317-1324.
198. Sreekantaiah C, De Braekeleer M, Haas O (1991) Cytogenetic findings in cervical carcinoma. A statistical approach. Cancer Genet Cytogenet 53:75-81.
199. Stephens JC, Cavanaugh ML, Gradie MI, Mador ML, Kidd KK (1990) Mapping the human genome: Current status. Science 250: 237-244.
200. Stoler A, Bouck N (1985) Identification of a single chromosome in the normal human genome essential for suppression of hamster cell transformation. Proc Natl Acad Sci USA 82:570-574.
201. Sugawara O, Oshimura M, Koi M, Annab LA, Barrett JC (1990) Induction of cellular senescence in immortalized cells by human chromosome 1. Science 247:707-710.
202. Sugimura T (1992) Multistep carcinogenesis: A 1992 perspective. Science 258:603-607.
203. Suzuki T, Yokota J, Mugishima H, Okabe I, Ookuni M, Sugimura T, Terada M (1989) Frequent loss of heterozygosity on chromosome 14q in neuroblastoma. Cancer Res 49:1095-1098.
204. Szpirer C, Rivière M, Szpirer, Genet M, Drèze P, Islam MQ, Levan G (1990) Assignment of 12 loci to rat chromosome 5: Evidence that this chromosome is homologous to mouse chromosome 4 and to human chromosomes 9 and 1 (1p arm). Genomics 6:679-684.
205. Taguchi T, Jhanwar SC, Siegfried JM, Keller SM, Testa JR (1993) Recurrent deletions of specific chromosomal sites in 1p, 3p, 6q, and 9p in human malignant mesothelioma. Cancer Res 53:4349-4355.
206. Takayama H, Suzuki T, Mugishima H, Fujisawa T, Ookuni M, Schwab M, Gehring M, Nakamura Y, Sugimura T, Terada M, Yokota J (1992) Deletion mapping of chromosomes 14q and 1p in human neuroblastoma. Oncogene 7:1185-1189.
207. Takeda O, Homma C, Maseki N, Sakurai M, Kanda N, Schwab M, Nakamura Y, Kaneko Y (1994) There may be two tumor suppressor genes on chromosome arm 1p closely associated with biologically distinct subtypes of neuroblastoma. Genes Chromosom Cancer 10:30-39.
208. Tanaka K, Yanoshita R, Konishi M, Oshimura M, Maeda Y, Mori T, Miyaki M (1993) Suppression of tumourigenicity in human colon carcinoma cells by introduction of normal chromosome 1p36 region. Oncogene 8:2253-2258.
209. Taylor CPF, McGuckin AG, Bown NP, Reid MM, Malcolm AJ, Pearson ADJ, Sheer D (1994) Rapid detection of prognostic genetic factors in neuroblastoma using fluorescene in situ hybridization on tumour imprints and bone marrow smears. Br J Cancer 69:445-451.
210. Tsuda H, Zhang W, Shimosato Y, Yokota J, Terada M, Sugimura T, Miyamura T, Hirohashi S (1990) Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc Natl Acad Sci USA 87:6791-6794.
211. Tsutsumi M, Yokota J, Kakizoe T, Koiso K, Sugimura T, Terada M (1989) Loss of heterozygosity on chromosomes 1p and 11p in sporadic Pheochromocytoma. J Nat Cancer Inst 81:367-370.
212. Tycko B, Smith SD, Sklar J (1991) Chromosomal translocations joining LCK and TCRB loci in human T cell leukemia. J Exp Med 174:867-873.
213. van der Drift P, Chan A, Laureys G, van Roy N, Sickmann G, den Dunnen J, Westerveld A, Speleman F, Versteeg R (1995) Balanced translocation in a neuroblastoma patient disrupts a cluster of small nuclear RNA U1 and tRNA genes in chromosomal band 1p36. Genes Chromosom Cancer 14:35-42.
214. van Haeringen A, Bergman W, Nelen MR, van der Kooij-Meijs E, Hendriksen I, Wijnen JT, Khan PM, Klasen EC, Frants RR (1989) Exclusion of the dysplastic naevus syndrome (DNS) locus from the short arm of chromosome 1 by linkage studies in Dutch families. Genomics 5:61-64.
215. van Roy N, Laureys G, Versteeg R, Opdenakker G, Speleman F (1993) High-resolution fluorescence mapping of 46 DNA markers to the short arm of human chromosome 1. Genomics 18:71-78.
216. Versteeg R, Caron H, Cheng NC, van der Drift P, Slater R, Westerveld A, Voûte PA, Delattre O, Laureys G, Van Roy N, Speleman F (1995) 1p36: Every subband a suppressor? Europ J Cancer 31A:538-541.
217. Vogelstein B, Fearon ER, Kern SE, Hamilton SR, Preisinger AC, Nakamura Y, White R (1989) Allelotype of colorectal carcinomas. Science 244:207-211.
218. Walker GJ, Palmer JM, Walters MK, Hayward NK (1995) A genetic model of melanoma tumorigenesis based on allelic losses. Genes Chromosom Cancer 12:134-141.
219. Wang N, Trend B, Bronson D, Fraley EE (1980) Nonrandom abnormalities in chromosome 1 in human testicular cancers. Cancer Res 40:796-802.
220. Weissenbach J, Gyapay G, Dib C, Vignal A, Morissette J, Millasseau P, Vaysseix G, Lathrop M (1992) A second-generation linkage map of the human genome. Nature 359:794-801.
221. Weith A, Martinsson T, Cziepluch C, Brüderlein S, Amler LC, Berthold F, Schwab M (1989) Neuroblastoma consensus deletion maps to 1p36.1-2. Genes Chromosom Cancer 1:159-166.
222. Welborn JL, Lewis JP, Jenks H, Walling P (1987) Diagnostic and prognostic significance of t(1;3)(p36;p21) in the disorders of hematopoiesis. Cancer Genet Cytogenet 28:277-285.
223. White PS, Kaufman BA, Marshall HN, Brodeur GM (1993) Use of the single-strand conformation polymorphism technique to detect loss of heterozygosity in neuroblastoma. Genes Chromosom Cancer 7:102-108.
224. White PS, Maris JM, Beltinger C, Sulman E, Marshall HN, Fujimori M, Kaufman BA, Biegel JA, Allen C, Hilliard C, Valentine MB, Look AT, Enomoto H, Sakiyama S, Brodeur GM (1995) A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3. Proc Natl Acad Sci USA 92:5520-5524.
225. Williams AC, Browne SJ, Yeudal WA, Paterson IC, Marshall CJ, Lane DP, Paraskeva C (1993) Molecular events including p53 and k-ras alterations in the in vitro progression of a human colorectal adenoma cell line to an adenocarcinoma. Oncogene 8:3063-3072.
226. Yamada J, Kuramoto T, Serikawa S (1994) A rat genetic linkage map and comparative maps for mouse or human homologous rat genes. Mammalian Genome 5:63-83.
227. Yang K-P, Nguyen CV, Castillo SG, Samaan NA (1990) Deletion mapping on the distal third region of chromosome 1p in multiple endocrine neoplasia type IIa. Anticancer Res 10:527-534.
228. Yeh S-H, Chen P-J, Chen H-L, Lai M-Y, Wang C-C, Chen D-S (1994) Frequent genetic alterations at the distal region of chromosome 1p in human hepatocellular carcinomas. Cancer Res 54: 4188-4192.
229. Young J, Searle J, Stitz R, Cowen A, Ward M, Chenevix-Trench G (1992) Loss of heterozygosity at the human RAP1A/Krev-1 locus is a rare event in colorectal tumors. Cancer Res 52:285-289.
230. Young J, Buttenshaw R, Butterworth L, Ward M, Searle J, Leggett B, Chenevix-Trench G (1994) Association of the SS genotype of the L-myc gene and loss of 18q sequences with a worse clinical prognosis in colorectal cancers. Oncogene 9:1053-1056.
231. Yunis JJ, Soreng AL (1984) Constitutive fragile sites and cancer. Science 226:1199-1204.
232. Zimonjic DB, Simpson S, Popescu NC, DiPaolo JA (1995) Molecular cytogenetics of human papillomavirus - negative cervical carcinoma cell lines. Cancer Genet Cytogenet 82:1-8.